8-KThe WireRoutine
Company Update
Filed Mar 30, 2026 · 3mo ago · Accession 0001140361-26-011991
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- 8-K
- Filing date
- Mar 30, 2026
- Report date
- Mar 30, 2026
- Document
- ef20069329_8k.htm
- Size
- 178 KB